"Polyphenotypic" tumors in the central nervous system: problems in nosology and classification.
In recent years, there is increasing recognition of polyphenotypic high-grade malignancies in the non-central nervous system (CNS) tumor literature. Some of these tumors have been regarded as variants of primitive neuroectodermal tumor (PNET) or as extrarenal malignant rhabdoid tumors (MRTs). This report concerns two posterior fossa neoplasms, both of which displayed a "polyphenotypic" expression of neural, epithelial, myogenic, and glial markers, including synaptophysin, neurofilament, vimentin, glial fibrillary acidic protein, S-100, neuron-specific enolase, desmin, S antigen, MIC2, cytokeratin, epithelial membrane antigen, and carcinoembryonic antigen. One tumor showed complex intercellular junctions, cytoplasmic intermediate filaments, well-developed rough and smooth endoplasmic reticulum and Golgi apparatus, cilia, and neurosecretory granules. The other neoplasm showed pools of glycogen, desmosomes, and tonofilaments. The histological and ultrastructural appearances were inconsistent with glioma, PNET, meningioma, ependymoma, choroid plexus carcinoma, sarcoma, germ cell tumor, and other tumors in the World Health Organization classification. Although the polyphenotype raises the issue that these may represent variants of MRT or the atypical teratoid-rhabdoid tumor, the morphologic findings in the two cases were very dissimilar. Our two cases underscore the problems in nosology and classification of polyphenotypic tumors of the CNS. This is particularly significant, as therapeutic protocols for PNET, MRT, and non-CNS polyphenotypic tumors are different. We review the literature on polyphenotypic tumors and reiterate the difficulties in precise classification of these complex tumors.
Jay
V
V
Division of Pathology (Neuropathology), Hospital for Sick Children, University of Toronto, Ontario, Canada.
Edwards
V
V
Halliday
W
W
Rutka
J
J
Lau
R
R
D015415:Biomarkers; D001932:Brain Neoplasms / Q000145:classification / Q000378:metabolism / Q000473:pathology; D002454:Cell Differentiation; D016543:Central Nervous System Neoplasms / Q000145:classification* / Q000378:metabolism / Q000473:pathology*; D003896:Desmosomes / Q000648:ultrastructure; D005260:Female; D006003:Glycogen / Q000378:metabolism; D006801:Humans; D007150:Immunohistochemistry; D007223:Infant; D008297:Male; D008854:Microscopy, Electron; D018242:Neuroectodermal Tumors, Primitive / Q000145:classification / Q000378:metabolism / Q000473:pathology; D010641:Phenotype; D018335:Rhabdoid Tumor / Q000145:classification / Q000378:metabolism / Q000473:pathology; D013724:Teratoma / Q000145:classification / Q000378:metabolism / Q000473:pathology; D009626:Terminology as Topic
D015415:Biomarkers; D006003:Glycogen